Stimdia Medical
Edina, US · Founded 2015 · Delaware corporation · 2 known investors
Find your way into Stimdia Medical
385 people in our graph share verified history with the Stimdia Medical team — schools, employers, funds. One of them is your warm intro.
Jackson Heddyunlockedknows Kristen Lechleiter · together at Arizona State University (overlapped)
×3knows the team · via Georgetown
×4knows the team · via Clemson University
×4knows the team · via UMN Carlson School of Management
Stimdia Medical develops neuromodulation technologies, with a leadership team focused on clinical and regulatory affairs and R&D in critical care and pulmonary medicine. The company operates in the medical device sector.
Founders & leadership
Stimdia Medical was founded in 2015 by Jay Katarincic and Jim Bullock.
JK
Jay KatarincicinCo-founder · Member Board Of Directors
JB
Jim BullockFounder, Stimdia Medical; Board Chairman
PW
Patrick WethingtoninExecutivePatrick Wethington is Founder and CEO of PredictiveOne, an AI-focused healthcare venture, and has held leadership and strategic roles across medical device companies including Guidant, Endocardial Solutions, CHF Solutions, CardioInsight, Stimdia Medical, and others, with experience spanning cardiac mapping, heart failure treatment, and neuromodulation technologies.
AM
Allen MeachaminPresident and Chief Executive Officer
BS
Brad SwatfagerChief Financial Officer
KL
Kristen LechleiterinVice President, Clinical and Regulatory AffairsKristen Lechleiter holds an M.S. in Biomedical Engineering from Washington University in St. Louis and brings over 15 years of life sciences industry experience, including clinical development leadership roles focused on medical device development and clinical research programs.
MM
Matt McDonaldinVice President, Research & Development
Investors · 2
Reported raises · per SEC filings
Form D private placements$21.1M disclosed across 4 rounds · 2015–2022
▶$16.1MraisedJun 2022 · 14 investors · Other Health CareRule 506(b)
▶$16.1MraisedJun 2022 · 14 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jay KatarinicDirector
- James BullockExecutive Officer, Director
- Offering amount
- $30.3M
- Amount sold
- $16.1M
- First sale
- Jun 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.9MraisedDec 2019 · 7 investors · Other Health CareRule 506(b)
▶$1.9MraisedDec 2019 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- James BullockExecutive Officer, Director
- Jay KatarinicDirector
- Offering amount
- $3.9M
- Amount sold
- $1.9M
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$1.1MraisedFeb 2018 · 4 investors · Other Health CareRule 506(b)
▶$1.1MraisedFeb 2018 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- James BullockDirector
- Jay KatarincicDirector
- Patrick WethingtonExecutive Officer, Director
- Offering amount
- $2.3M
- Amount sold
- $1.1M
- Minimum investment
- $1
- First sale
- Jan 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$1.9MraisedDec 2015 · 4 investors · Other Health CareRule 506(b)
▶$1.9MraisedDec 2015 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Patrick J WethingtonExecutive Officer, Director
- J.A. Katarincic, Jr.Director
- James BullockDirector
- Offering amount
- $1.9M
- Amount sold
- $1.9M
- Minimum investment
- $1
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlap
Cqmedical8 shared keywordsCQ Medical develops patient positioning and immobilization products used in radiation therapy, including devices for brachytherapy, SBRT, SRS, and proton treatments. Its offerings serve oncology and radiotherapy clinicians treating cancer and conditions such as osteoarthritis.
Medidata7 shared keywordsMedidata is a clinical trial software platform that serves pharmaceutical, biotech, and healthcare organizations conducting clinical research. It provides end-to-end trial management, patient data analytics, and regulatory compliance solutions across thousands of trials and millions of patients globally.
DiaMedica Therapeutics7 shared keywordsDiaMedica Therapeutics develops therapies aimed at reducing ischemia in patients with serious vascular diseases, with an initial focus on preeclampsia, fetal growth restriction, and acute ischemic stroke. It is a clinical-stage biopharmaceutical company working on treatments for ischemic disorders.
Mobiamedical6 shared keywordsMobia Medical (formerly MicroTransponder) develops Vivistim Paired VNS Therapy, an FDA-approved vagus nerve stimulation treatment for chronic ischemic stroke survivors with moderate to severe upper extremity impairment. It serves stroke patients and the clinicians who treat them in the medical device industry.
Companies competing with Stimdia Medical for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Stimdia Medical do?
- Stimdia Medical develops neuromodulation technologies, with a leadership team focused on clinical and regulatory affairs and R&D in critical care and pulmonary medicine. The company operates in the medical device sector.
- Who founded Stimdia Medical?
- Stimdia Medical was founded by Jay Katarincic, Jim Bullock in 2015.
- Who are Stimdia Medical's investors?
- Stimdia Medical's investors include Solas BioVentures, Fresenius Medical Care Ventures.
- How much funding has Stimdia Medical raised?
- Stimdia Medical has disclosed $21.1M raised across 4 rounds.
- Where is Stimdia Medical headquartered?
- Stimdia Medical is headquartered in Edina, US.